
Iberian Healthcare Collaboration: Spain & Portugal Unite for Health Technology Assessments!
Recent Posts
Urgent Call for Enhanced Precision Oncology Access in Europe
EFPIA White Paper: Unlocking Precision Oncology Access in Europe
The EFPIA Oncology Platform's white paper, "Advancing Precision Oncology Treatment and Testing Across Europe," launched on March 5, 2026, at a high-level...
Harmonizing Non-Clinical Evaluation of Microbiome Medicinal Products in the EU
EMA's Push for Microbiome Medicinal Products Guidance
EMA's Non-Clinical Working Party has drafted a concept paper, adopted by CHMP on 16 February 2026, proposing a reflection paper to guide non-clinical development of microbiome...
Tirzepatide Cost Effectiveness: A Winning Strategy for Type 2 Diabetes Management
Tirzepatide Cost Effectiveness in UK T2D Care
Evaluating tirzepatide cost effectiveness reveals significant advantages over semaglutide 1 mg for patients with type 2 diabetes (T2D) inadequately controlled on metformin, based on a